Differentiation-linked expression of the plasminogen activator inhibitor type-2 gene in the human HL-60 promyelocytic cell line.
HL-60 is a human promyelocytic cell line which was found to be capable of differentiating toward a macrophage-like or granulocyte-like phenotype. Histochemical analysis demonstrated that incubation of cells in the presence of phorbol myristate acetate (PMA) or 1,25-dihydroxyvitamin D3 induced varying degrees of monocytic differentiation, while incubation in the presence of retinoic acid (RA) or dimethyl sulfoxide (DMSO) induced granulocytic differentiation. The differentiation induced by PMA, RA, and to a lesser extent DMSO, was accompanied by the induction of plasminogen activator inhibitor expression. mRNA analysis of control and PMA-induced cultures revealed the induction of a 2-kb message in treated cells which hybridized with a PAI-2-specific oligonucleotide probe. This is consistent with the literature concerning the expression of PAI by macrophages and granulocytes. No hybridization was detected with a PAI-1 specific probe. Expression of PAI by cells of hematopoietic origin appears to be associated with differentiation or stimulation of committed cells. Furthermore, PAI-2 expression by HL-60 cells is not restricted to one specific hematopoietic lineage. Since other cells of hematopoietic origin such as platelets express PAI-1, future studies using pluripotential cell lines could provide information on the initial events of lineage commitment and gene expression.
Arndt
A D
AD
Joint Injury and Diseases Research Group, University of Calgary Health Sciences Centre, Alberta, Canada.
Gohill
J
J
Rankin
K
K
Houwen
B
B
Hart
D A
DA
D002454:Cell Differentiation; D002460:Cell Line; D015972:Gene Expression Regulation, Neoplastic; D005796:Genes / Q000187:drug effects; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute; D015849:Plasminogen Inactivators; D011257:Pregnancy Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000302:isolation & purification; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism
D015849:Plasminogen Inactivators; D011257:Pregnancy Proteins; D012334:RNA, Neoplasm; D013755:Tetradecanoylphorbol Acetate